Use Of Sahajan

न्यूयॉर्क: शोधकर्ताओं का कहना है कि 60 साल या उससे अधिक आयु के मरीजों को जितना अधिक एंटीबायोटिक दिया जायेगा, उतना ही उनके इंफ्लेमेटरी बाउल डिजीज (आईबीडी) से ग्रसित होने की संभावना बढ़ती जायेगी। न्यूयॉर्क यूनिवर्सिटी के ग्रॉसमैन स्कूल ऑफ मेडिसिन के शोधकर्ता एडम एस फाये के अनुसार, 60 साल और उससे अधिक आयु के लोगों के क्रॉन बीमारी और अल्सरेटीव कोलाइटिस से ग्रसित होने में एंटीबायोटिक दवाओं के सेवन की भूमिका रही है। शोध अध्ययन के दौरान 23 लाख मरीजों के रिकॉर्ड की समीक्षा की गई। शोधकर्ताओं का कहना है कि दूसरे व्यस्कों में पर्यावरणीय कारक जेनेटिक्स से अधिक महत्वपूर्ण हैं। उन्होंने कहा कि जब क्रॉन बीमारी और अल्सरेटीव कोलाइटिस से ग्रसित युवा मरीजों के रिकॉर्ड को देखा जाये तो पता चलेगा कि उनकी फैमिली हिस्ट्री मजबूत रही है। लेकिन अधिक आयु के लोगों के मामले में ऐसा नहीं है यानी पर्यावरण में कुछ ऐसा है जिससे यह हो रहा है। शोधकर्ताओं ने डेनमार्क के नेशनल डाटाबेस का इस्तेमाल किया। यह सभी लोगों के मेडिकल रिकॉर्ड का डाटाबेस है। शोधकर्ताओं ने 2000 से 2018 के बीच आईबीडी से ग्रसित होने वाले 60 साल और उससे अधिक आयु के लोगों को लिखी जाने वाली दवाओं के रिकॉर्ड देखे। शोधकर्ताओं ने देखा कि उन मरीजों को एंटीबायोटिक का कौन सा कोर्स किया है और उन्होंने हाल ही में कब एंटीबायोटिक ली थी। उन्होंने पाया कि एंटीबायोटिक के इस्तेमाल से आईबीडी से ग्रसित होने की संभावना बढ़ जाती है और जैसे-जैसे मरीज अन्य एंटीबायोटिक का कोर्स करता है, वैसे-वैसे यह संभावना भी बढ़ती जाती है। एक कोर्स के बाद मरीज के आईबीडी से ग्रसित होने की संभावना 27 प्रतिशत अधिक बढ़ जाती है। एंटीबायोटिक का दो कोर्स करने पर यह जोखिम 55 प्रतिशत और तीन कोर्स करने पर 67 प्रतिशत बढ़ जाती है। चार कोर्स करने पर यह संभावना 96 प्रतिशत और पांच या उससे अधिक कोर्स करने पर 236 प्रतिशत बढ़ जाती है। (एजेंसी) यह भी पढ़े► लिथियम की कम डोज किडनी के लिये वरदान: शोध

Prime Minister Narendra Modi on Wednesday announced a special Ayush mark for Ayush products among many new initiatives for Ayush sector, on the occasion of Global Ayush Investment & Innovation Summit 2022. The Prime Minister on Wednesday inaugurated the three-day Global Ayush Investment & Innovation Summit 2022 at Gandhinagar in the presence of the Prime Minister of Mauritius Pravind Kumar Jugnauth, WHO Director General, Tedros Adhanom Ghebreyesus, Union Health Minister Mansukh Mandaviya, Union Ayush Minister Sarbananda Sonowal, Gujarat Chief Minister Bhupendra Patel and others. In his inaugural address, Modi said: "We are already witnessing unprecedented growth in the production of Ayush medicines, supplements and cosmetics. In 2014, where the Ayush sector was less than $3 billion, today it has increased to more than $18 billion. An unprecedented efforts has been made in the past years to promote the export of Ayush products." Along with first being a special Ayush mark for Ayush products, Modi announced many other initiatives for Ayush sector. A new category named 'Ayush Aahar' was announced which will greatly facilitate the producers of herbal nutritional supplements. Further, another major initiative for foreign nationals who want to come to India to take advantage of Ayush therapy was announced. India will soon introduce a special Ayush visa category. Describing the current age of the era of unicorns, the Prime Minister informed that in the year 2022 itself, so far 14 start-ups from India have joined the Unicorn Club. "I am sure unicorns will emerge from our Ayush start-ups very soon", he stated. Prime Minister also announced launch of Ayush Export Promotion Council and four Ayush ICT initiatives which includes Ayush Information Hub, AyuSoft, Ayush Next and Ayush GIS. The Prime Minister also released a comic book named 'Professor Ayushman', which describes how Ayush systems and products helped in fighting not only Covid-19 but other diseases also. Addressing the session, Tedros said that the Ayush sector is growing significantly by 17 per cent per year since 2014. He said that Ayush industry is projected to reach $23 billion by the end of this year. "We are exploring innovative study designs and the use of artificial intelligence to document the impact of traditional medicine practices, in cases when standard randomised trials are not possible or are difficult to undertake. "Strengthening the evidence base of traditional medicine should facilitate its use by communities, to promote better health outcomes, economic benefits and overall impact," he added. Read More► PM Launches Ayush Visa for Medical Tourists

Kamini Vidrawan Ras is an effective ayurvedic medicine that helps to treat men's health problems. It is useful in sexual vitality, erectile dysfunction, premature ejaculation. It is manufactured by the renowned ayurvedic companies baidyanath, multani. Kamini Vidrawan Rasa is a typical Ayurvedic medicine enriched with the goodness of Ayurvedic herbs and ingredients. The main ingredients of Kamini Vidrawan Ras are Betel leaves, Akarkara, Sandalwood, Nutmeg, Clove, Poppy Seeds and other ingredients mentioned in the ingredients section. The main effects are observable in cases of premature ejaculation. It delays ejaculation and improves men's stamina. It has aphrodisiac effects and is widely recommended by Ayurvedic doctors to enhance and maintain an erection, improve vitality and treat infertility. It is 100% Ayurvedic and safe and available in gel form in the market. Kamini Vidrawan Rasa dosage depends on the age, gender, weight, and condition of the patient. So let's start this article in which you will get complete information about Kamini Vidrawan Rasa. Kamini Vidrawan Ras Ingredients Ingredients that are used in the Kamini Vidrawan Ras: Betel leaves Akarkara Sandalwood Nutmeg Clove Ginger Saffron Poppy Seeds Kamini Vidrawan Ras Benefits Some of the health benefits of Kamini Vidrawan Ras include its ability to maintain a penile erection for longer, increase strength, relieve pain, and control muscle contractions. Erectile Dysfunction Kamini Vidrawan Ras has aphrodisiac properties and is commonly prescribed by Ayurvedic doctors to improve penile erection, vitality and fertility. It also improves the hardness and firmness of the penis. Contains Shuddha Ahiphena, which is helpful in maintaining a penile erection for a long time and increases pleasure in lovemaking. For better results, it can be taken together with Makardhwaj Vati. Premature Ejaculation Kamini Vidrawan Ras contains several ingredients that improve the erection and keep it for longer. Therefore, it also prevents premature ejaculation. In case of premature ejaculation, it should be taken along with Yashtimadhu Churna for best results. Loss of Libido Kamini Vidrawan Ras is extremely beneficial for men to increase virility and improve sexual health. It also increases libido in men. It is an effective Ayurvedic medicine to treat frigidity. Shuddha Ahiphena in it also acts on psychological problems that affect libido or cause impotence. Therefore, it is a very effective medication for men suffering from loss of libido and erectile dysfunction. It improves the stimulation and helps to achieve a better orgasm. It is also beneficial in the treatment of Oligospermia, nightfall, Male Infertility and impotence. Kamini Vidrawan Ras Side Effects The most common side effect of Kamini Vidrawan Ras is constipation as it contains Ahiphena. This effect can be minimized by drinking warm water early in the morning and immediately after waking up. Kamini Vidrawan Ras should not be taken on a regular basis. It should be for occasional use only. Its regular use can lead to addiction. Therefore, it is advisable to avoid its excessive use. Kamini Vidrawan Ras Dosage Kamini Vidrawan Ras Dosage: 1/2 to 1 tablet twice a day with lukewarm milk. Best time to take one hour before bedtime or as directed by the Ayurvedic doctor. Kamini Vidrawan Ras Shelf Life Kamini Vidrawan Ras shelf life is best 2 years from the manufacturing date. Kamini Vidrawan Ras Storage & Safety Information Kamini Vidrawan Ras storage and safety information are: Read the label carefully before use Protect from direct sunlight Use under medical supervision Store in a cool and dry place Kamini Vidrawan Ras Frequently Asked Questions Q. What is Kamini Vidrawan Ras? Ans. Kamini Vidrawan Ras helps to treat men's health problems. It is useful in sexual vitality, erectile dysfunction, premature ejaculation. Q. How much shelf life has Kamini Vidrawan Ras had? Ans. Kamini Vidrawan Ras shelf life is best 2 years from the manufacturing date. Q. How to use Kamini Vidrawan Ras? Ans. 1/2 to 1 tablet twice a day with lukewarm milk. Best time to take one hour before bedtime or as directed by the Ayurvedic doctor. Q. Is Kamini Vidrawan Ras safe? Ans. Yes, Kamini Vidrawan Ras helps to treat men's health problems. It is useful in sexual vitality, erectile dysfunction, premature ejaculation. Q. Does Kamini Vidrawan Ras have any chemical ingredients? Ans. Kamini Vidrawan Ras is also made from natural herbs like Betel leaves akarkara, sandalwood, nutmeg, clove, ginger, saffron, and no kind of artificial ingredient has been used in its making. Q. What is Kamini Vidrawan Ras used for? Ans. Kamini Vidrawan Ras helps to treat men's health problems. It is useful in sexual vitality, erectile dysfunction, premature ejaculation. Q. Does the Kamini Vidrawan Ras work? Ans. Kamini Vidrawan Ras may play a beneficial role that helps to treat men's health problems. It is useful in sexual vitality, erectile dysfunction, premature ejaculation. Q. Is Kamini Vidrawan Ras effective? Ans. Yes, Kamini Vidrawan Ras is an effective formula. Q. Does Kamini Vidrawan Ras have any side effects? Ans. The most common side effect of Kamini Vidrawan Ras is constipation as it contains Ahiphena. This effect can be minimized by drinking warm water early in the morning and immediately after waking up. Kamini Vidrawan Ras should not be taken on a regular basis. It should be for occasional use only. Its regular use can lead to addiction. Therefore, it is advisable to avoid its excessive use. Kamini Vidrawan Ras Reference Bhaishajya Ratnavali, Chapter 75, Viryastambhan Prakarana, Verse किसी भी प्रकार की दवाई लेने से पहले डॉक्टर से सलाह लेना आवश्यक है। आयुर्वेद के अनुभवी डॉक्टर से निशुल्क: परामर्श लें @ +91-9205773222

Instances of dubious claims and misleading advertisements of Ayush products have come to the notice of the Central Government. The Pharmacovigilance Centres for Ayurveda, Siddha, Unani and Homoeopathy Drugs set up in different parts of the country have reported 18812 objectionable advertisements since 2018 to December, 2021. On the Grievance against Misleading Advertisement (GAMA) portal of Department of Consumer Affairs, 1416 misleading advertisements of Ayush productsand services have been registered from April 2014 to July 2021. Further, in the year 2017-19, Advertising Standards Council of India (ASCI) under MoU with Ministry of Ayush has reported 1229 misleading advertisements of Ayush products. The protocol or guidelines are in force to restrict Ayush products of medicinal use with dubious claims and for selling certain medicines under medical supervision. The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules there under encompass the provisions for prohibition of misleading advertisements and exaggerated claims of drugs and medicinal substances including Ayush medicines and for the penalty to be imposed on the defaulters. The State/UT Governments are empowered to enforce the legal provisions under Drugs & Cosmetics Act, 1940 and the Drugs & Magic Remedies (Objectionable Advertisements) Act, 1954 and rules made there under.  The Pharmacovigilance Centres for Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) Drugs set up in different parts of the country under the Central Sector Scheme of Ministry of Ayush are mandated to monitor and report misleading advertisements to the respective state Drug Licensing Authorities for taking appropriate action under the provisions of Drugs & Cosmetics Act, 1940 and the Drugs & Magic Remedies (Objectionable Advertisements) Act, 1954. Media regulators have also been approached to prevent the publication of inappropriate advertisements promoting sale of Ayurvedic and other such medicines in public interest. On this account, Ministry of Information & Broadcasting issued instructions/guidelines to all media channels to abstain from publishing and telecasting such misleading advertisements, which are in contravention of provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder. Ministry of Ayush issued an Advisory dated 31st August 2018 to the drug manufactures and the advertising agencies to refrain from using the name of Government Departments or Institutions in the advertisements of ASU & H Drugs. Also, Caution has been issued in November 2018 in leading newspapers for general public to not to fall prey to fake calls and advertisements of ASU & H Drugs. With the enforcement of these steps the advertisers have corrected or withdrawn the improper advertisements. Also, as per the provision of Rule 161 of Drugs Rules, 1945, it is mandatory for the container of a Ayurvedic, Siddha and Unani medicine for internal use to be labeled conspicuously with the words 'Caution to be taken under medical supervision’ both in English and Hindi languages, if the ingredients are made up from a substance (poisonous) specified in Schedule E(1). This information was given by Minister of Ayush Shri Sarbananda Sonowal in a written reply in Rajya Sabha. Read More► Argentina Federal Police to effectively use Yoga for stress management of its personnel